Confirmed influenza pneumonia
top of page
Internal Medicine
Public·109 members
Donohue JF et al. Ensifentrine as a novel, inhaled treatment for patients with COPD. Int J Chron Obstruct Pulmon Dis 2023 Jul 28; 18:1611. (https://doi.org/10.2147/COPD.S413436)
Population:
Patients with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD).
Approximately 1500 participants involved in the trials (ENHANCE-1 and ENHANCE-2).
Intervention:
Administration of Ensifentrine (Ohtuvayre), a novel phosphodiesterase 3 and 4 inhibitor, via nebulizer.
Early home discharge in low-risk PE patients, as identified by validated triage tools (sPESI and Hestia), is safe with very low incidences of adverse events and mortality. However, patients with cancer, elevated troponin, or elevated NT-proBNP have a higher risk of adverse events and may require closer monitoring.
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis | European Heart Journal | Oxford Academic (oup.com)
Samir Al-Nasseri
Dec 19, 2024
Dr. Mazen, I could not see any devices except multiple ECG cables. Could you please explain with marks on the image. Great thanks.
A 42-year-old man with progressive cough, fever, and shortness of breath for three weeks. Here are the key points and findings:
Medical Conditions: Hyperlipidemia and hypertension.
Medications: Atorvastatin 20 mg daily, lisinopril 10 mg daily.
Lifestyle: Non-smoker.
Recent Activity: Recently placed mulch in his yard.
Physical Examination:
42-year-old man with progressive cough, fever, and shortness of breath for three weeks. He recently placed mulch in his backyard.
Patient History:
Medical Conditions: Hyperlipidemia and hypertension.
Medications: Atorvastatin 20 mg daily, lisinopril 10 mg daily.
Lifestyle: Non-smoker.
Recent Activity: Recently placed mulch in his yard.
Symmetric diffuse, bilateral pulmonary infiltrates with mediastinal and bilateral hilar lymphadenopathy. DDx?
What do you want to do next?
Mazen Kherallah
May 15, 2024
Thank you, in addition to the pneumomediastinum and SQ emphysema, there is also a pneumothorax on the right side and a chest tube is needed since this patient is on the ventilator. @Everyone
Determining CD4+/CD8+ ratio can be helpful in the diagnosis of sarcoidosis. Sarcoidosis is characterized by an increased CD4/CD8 ratio (>3.5), compared with other interstitial lung diseases.
A 57-year-old sarcoidosis patient is showing "cobblestone" appearance in the endobronchial Biopsy proved multiple non-necrotizing granulomas.
Bilateral pneumonia